Company Served as Sponsor and Provided Operational Leadership for Study Conducted in Partnership with TGen and Virta ...
Morning Overview on MSN
Study finds cancer drugs can pool in tumor cell hubs, fueling resistance
Cancer drugs like cisplatin are designed to attack tumor cells, but new research shows these therapies can concentrate inside specialized molecular clusters within the nucleus, altering how ...
The prospective, multicenter phase 2 RACE-IT trial evaluated the safety of neoadjuvant radiation plus immunotherapy before radical cystectomy for bladder cancer.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announces that it has entered into an agreement ...
Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announces that it has entered into an agreement with Cipla Limited and Cipla USA, Inc. to settle the ...
A new analysis explores whether accelerating RT delivery with 6 fractions vs 5 fractions per week improves outcomes in patients with locally advanced HNSCC receiving concurrent chemotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results